1-3 of 3
Arghya Ray, Ph.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SL-401, A Novel Targeted Therapy Directed To The Interleukin-3 Receptor (IL-3R), Inhibits Plasmacytoid Dendritic Cell (pDC)-Induced Myeloma Cell Growth and Overcomes Drug Resistance

Arghya Ray, Ph.D, Deepika Sharma Das, Ph.D., Ze Tian, Ph.D, Vincent Macri, Christopher L. Brooks, PhD, Paul G. Richardson, MD, Eric Rowinsky, MD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2013) 122 (21): 3170.
https://doi.org/10.1182/blood.V122.21.3170.3170
Published: 2013
Journal Articles

Kinase Domain Mutations in JAK2V617F Confer Resistance to the Novel JAK2 Inhibitor Ruxolitinib

Anagha Deshpande, PhD, Mamatha M. Reddy, PhD, Georg Schade, Arghya Ray, Ph.D, Tirumala K. Chowdary, PhD, James D. Griffin, MD, Martin Sattler, PhD
Journal: Blood
Blood (2011) 118 (21): 125.
https://doi.org/10.1182/blood.V118.21.125.125
Published: 2011
Journal Articles

A Novel Acanthoic Acid Analog NPI-1342 Blocks IκB Kinase-α and Trigger In Vitro and In Vivo cytotoxicity in Multiple Myeloma Cells

Dharminder Chauhan, PhD, Ajita V. Singh, Arghya Ray, Ph.D, Teru Hideshima, MD, PhD, Paul G. Richardson, MD, Michael A. Palladino, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2011) 118 (21): 1841.
https://doi.org/10.1182/blood.V118.21.1841.1841
Published: 2011